ODDB.org: Open Drug Database

Phesgo 600 mg/600 mg/10 ml, Injektionslösung -

Swissmedic Key	67828001	Registration Holder	Roche Pharma (Schweiz) AG
Name	Phesgo 600 mg/600 mg/10 ml, Injektionslösung	Date of registration	08.04.2021
		Introduction of Sequence	08.04.2021
ATC-Classification	(L01FY01)	Revision date
WHO	WHO-DDD	Valid until	07.04.2026
Index Therapeuticus (BSV)	07.16.10.	Show package size
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	3719.73	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	4061.85
Feedback	FB
GTIN	7680678280015	Medication Code	Biotechnologika
Pharmacode		Disponibility

Composition

pertuzumabum 600 mg, trastuzumabum 600 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, saccharum, polysorbatum 20, dl-methioninum, aqua ad iniectabile q.s. ad solutionem pro 10 ml.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Pertuzumabum	600mg / 10ml
Trastuzumab	600mg / 10ml

BAG: Active Agent	Dose
Pertuzumabum	600 mg
Trastuzumab	600 mg

Inactive agents
DL-Methionine
Histidin Hydrochloride Monohydrate
Histidine
Hyaluronidasum Humanum Adnr
Polysorbatum 20
Saccharum
Trehalosum Dihydricum

Source

Data was imported : 04.12.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH